Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
The primary progressive multiple sclerosis (PPMS) treatment market size is expected to reach $1.92B by 2029 at a 13.5% CAGR, driven by innovative therapies, advanced diagnostics, and personalized medicine.